Atorvastatin Calcium
Product Images NDC 42254-019

5 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 42254-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (2a8de5aa 936a 493e A0e3 813cbc969c6d 01)

Chemical Structure (2a8de5aa 936a 493e A0e3 813cbc969c6d 01)
Chemical structure of atorvastatin calcium, shown as a complex molecular diagram including aromatic rings, hydroxyl groups, and calcium ions with associated water molecules.*
FDA Label Image

Figure 1 (2a8de5aa 936a 493e A0e3 813cbc969c6d 02)

Figure 1 (2a8de5aa 936a 493e A0e3 813cbc969c6d 02)
A line graph showing cumulative incidence (%) over 3.5 years comparing Atorvastatin with placebo. The graph depicts two lines, one solid for Atorvastatin and one dashed for placebo, indicating lower cumulative incidence for Atorvastatin. The hazard ratio and p-value are also shown below the x-axis.*
FDA Label Image

Figure 2 (2a8de5aa 936a 493e A0e3 813cbc969c6d 03)

Figure 2 (2a8de5aa 936a 493e A0e3 813cbc969c6d 03)
A line chart comparing cumulative hazard percentages over approximately 5 years between placebo and atorvastatin groups. The x-axis represents time from first primary endpoint through four years of follow-up in years, and the y-axis represents cumulative hazard as a percentage. The chart includes hazard ratio data indicating a lower hazard for atorvastatin compared to placebo.*
FDA Label Image

Figure 3 (2a8de5aa 936a 493e A0e3 813cbc969c6d 04)

Figure 3 (2a8de5aa 936a 493e A0e3 813cbc969c6d 04)
A Kaplan-Meier survival curve graph depicting the percentage of subjects experiencing a major cardiovascular event over a period of 5 years. The graph compares two doses of atorvastatin, 10 mg and 80 mg, showing the time to first major cardiovascular endpoint on the x-axis and the percentage of subjects experiencing the event on the y-axis.*
FDA Label Image

Atorvastatin Calcium 40mg (2a8de5aa 936a 493e A0e3 813cbc969c6d 05)

Atorvastatin Calcium 40mg (2a8de5aa 936a 493e A0e3 813cbc969c6d 05)
Atorvastatin Calcium 40mg tablets packaging label by Rebel Distributors Corp. The label indicates a quantity of 90 tablets and includes the NDC number 42254-019-90. The product is distributed by Physician Partner in Thousand Oaks, CA, and manufactured by Pfizer Pharmaceuticals LLC Puerto Rico. Storage instructions specify controlled room temperature of 15°-30°C (59°-86°F). The label also features a barcode and the notation 'RX Only.'*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.